Interoceptive Awareness, Physical Activity, Body Awareness and Emotional Status in Individuals With Non-Specific Chronic Low Back Pain

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorIstinye University

About this trial

This observational cross-sectional study aims to examine the relationships between interoceptive awareness, physical activity level, body awareness, emotional status, and pain intensity in individuals with non-specific chronic low back pain. Non-specific chronic low back pain refers to pain in the lumbar region lasting for at least three months without an identifiable structural or pathological cause.

Participants aged 18-65 years who meet the diagnostic criteria for non-specific chronic low back pain will be evaluated using validated self-report questionnaires. These include measures of interoceptive awareness, body awareness, alexithymia, physical activity level, and pain intensity. Sociodemographic and clinical characteristics such as age, gender, education level, duration of pain, medication use, height, weight, and BMI will also be collected.

The purpose of the study is to better understand how internal body perception, physical activity, emotional processing, and body awareness interact with pain experience in this population. Findings may contribute to the development of individualized rehabilitation programs and inform clinicians about the multidimensional factors influencing chronic low back pain.

Eligibility criteria

Qualifiers

Adults aged 18-65 years.

Diagnosed with non-specific chronic low back pain.

Duration of pain ≥ 3 months.

Self-reported average pain score ≥ 4/10 on the Visual Analog Scale.

Disqualifiers

Low back pain due to specific pathologies (e.g., tumor, infection, fracture, inflammatory disease).

Serious systemic, neurological, or psychiatric comorbidities.

History of spinal surgery within the past year.

Pregnancy.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

130 Participants
are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators